Guidelines for minimal information on cellular senescence experimentation in vivo
Ludwig Boltzmann Gesellschaft · Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA · +49 more institutions
Abstract
Cellular senescence is a cell fate triggered in response to stress and is characterized by stable cell-cycle arrest and a hypersecretory state. It has diverse biological roles, ranging from tissue repair to chronic disease. The development of new tools to study senescence in vivo has paved the way for uncovering its physiological and pathological roles and testing senescent cells as a therapeutic target. However, the lack of specific and broadly applicable markers makes it difficult to identify and characterize senescent cells in tissues and living organisms. To address this, we provide practical guidelines called "minimum information for cellular senescence experimentation in vivo" (MICSE). It presents an…
Citation impact
- FWCI
- 78.46
- Percentile
- 100%
- References
- 169
Authors
32- MOMikołaj OgrodnikCorresponding
Ludwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, Austrian Cluster for Tissue Regeneration, Ludwig Boltzmann Institute for Digital Health and Prevention
- JCJuan Carlos Acosta
Universidad de Cantabria, Edinburgh Cancer Research, Instituto de Biomedicina y Biotecnología de Cantabria
- PDPeter D. Adams
Sanford Burnham Prebys Medical Discovery Institute, Discovery Institute
- FDFabrizio d’Adda di Fagagna
IFOM, Istituto di Genetica Molecolare
- DJDarren J. Baker
Mayo Clinic, WinnMed
Topics & keywords
- Biology
- Senescence
- In vivo
- Cell biology
- Cellular senescence
- Computational biology
- Genetics
- Phenotype
Funding
- GFGlenn Foundation for Medical Research
- PPfizer
- BUBrown University
- CRCancer Research Society
- MKMerck KGaA
- BIBuck Institute for Research on Aging
- NFNoaber Foundation
- OCOvarian Cancer Canada
- CRCancer Research UKAward: C15075/A28647
- ICImperial College LondonAward: H2020
- ECEuropean CommissionAwards: H2020, 857524, POR FESR 2014-2020, 2014-2020, 825575, 835103, 70/3/8916, 856487
- DFDeutsche ForschungsgemeinschaftAwards: 450807335, 825575, 450627322, CRC 1506, 497658823, CRC1506, GRK 1789, 22137416
- ZZonMw
- ASAustrian Science FundAwards: P36483, P35268, P37321, P35382
- FPFondation pour la Recherche Médicale
- NONederlandse Organisatie voor Wetenschappelijk OnderzoekAward: 09150172010029
- GSGeneral Secretariat for Research and TechnologyAwards: 2020SE01300001, H2020
- HFHerzfelder'sche Familienstiftung
- AIAssociazione Italiana per la Ricerca sul CancroAwards: 21762, 21091
- UFUniversität für Bodenkultur Wien
- AUAllgemeine Unfallversicherungsanstalt
- ZFZentrum für Regenerative Therapien Dresden
- RLRegione LombardiaAwards: 2014-2020, POR FESR 2014-2020, FESR 2014-2020
- LBLudwig Boltzmann Gesellschaft
- FRFondazione Regionale per la Ricerca BiomedicaAward: 825575
- NINational Institutes of HealthAwards: U54 AG076041, R01AG82708, R01AG068048, AG031862, R01 AG068182, UG3CA268103, R37AG013925, P01 AG031862, R33AG061456, ASAP-000592, H2020
- H2Horizon 2020 Framework ProgrammeAwards: 825575, 857524
- NSNatural Sciences and Engineering Research Council of Canada
- FDFonds de Recherche du Québec - SantéAwards: 281706, 33070, 22624
- MRMedical Research CouncilAward: MC_U120085810
- BABiotechnology and Biological Sciences Research CouncilAward: BB/S006710/1
- EREuropean Regional Development FundAwards: FESR 2014-2020, H2020, 2014-2020, POR FESR 2014-2020
- AEAgencia Estatal de InvestigaciónAward: H2020